Navigation Links
Westaim Announces Recommendation from RiskMetrics Group
Date:3/15/2010

TORONTO, March 15 /PRNewswire-FirstCall/ - The Westaim Corporation (Westaim or the Company) (TSX: "WED") announces that RiskMetrics Group (formerly Institutional Shareholder Services or "ISS") is recommending that its clients vote in favour of approving the financing resolution to be submitted to shareholders of Westaim at a special meeting of shareholders scheduled for March 25, 2010 (the Financing Resolution). The Financing Resolution relates to the issuance of up to 550 million common shares of Westaim, issuable on the conversion of an equal number of subscription receipts, recently sold by way of private placement. The subscription receipts were sold to finance the previously announced acquisition of JEVCO Insurance Company (JEVCO) from Kingsway Financial Services Inc.

RiskMetrics is widely recognized as one of the leading independent proxy voting and corporate governance advisory firms. Their analyses and recommendations are relied upon by many major institutional investment firms, mutual funds and fiduciaries throughout North America.

In its report issued on March 11, 2010 recommending that its clients vote to approve the Financing Resolution, RiskMetrics stated*:

        "WED has been searching for a new strategic investment opportunity.
        (Her Majesty the Queen in Right of the Province of Alberta) is
        expected to be a strong financial partner and the proposed
        transformational transaction provides WED with a new focus."

        "Management believes the acquisition will help create long term
        value...Market reaction has been positive and the stock is trading at
        its 52-week high."

"We are pleased that RiskMetrics supports our view that Westaim shareholders should vote FOR the Financing Resolution," said Cameron MacDonald, Westaim's President and Chief Executive Officer. "We urge shareholders not to delay voting their proxy, in order to ensure it is received in time to be counted at the Special Meeting."

A Management Information Circular, dated February 26, 2010 has been mailed to shareholders and filed on SEDAR (www.sedar.com) and Westaim's web page (www.westaim.com). The Circular contains, among other items, details regarding the Financing Resolution, the sale of the subscription receipts, the terms of the acquisition, the business of JEVCO and certain historical and pro forma financial information relating to JEVCO and Westaim.

About the Special Meeting

The Special Meeting (the "Meeting") of shareholders of The Westaim Corporation will be held at St. Andrew's Club and Conference Centre, 150 King Street West, 27th Floor, Toronto, Ontario, Canada on March 25, 2010 at 10:00 a.m. (Toronto time).

Shareholders who require assistance in voting their proxy may direct their inquiry to Westaim's proxy solicitation agent, Kingsdale Shareholder Services, 1-888-518-6813 or contactus@kingsdaleshareholder.com

About Westaim

Westaim invests, directly and indirectly, through acquisitions, joint ventures and other arrangements, with the objective of providing its shareholders with capital appreciation and real wealth preservation. Westaim's common shares are listed on The Toronto Stock Exchange under the trading symbol WED.

Certain portions of this press release as well as other public statements by Westaim, contain forward-looking statements. Such forward-looking statements include but are not limited to statements concerning the transaction described herein; investment strategies and expected rates of return; and strategic alternatives to maximize value for shareholder. These statements are based on current expectations that are subject to risks, uncertainties and assumptions and Westaim can give no assurance that these expectations are correct. Westaim's actual results could differ materially from those anticipated by forward-looking statements for various reasons generally beyond our control, including but not limited to: (i) failure to complete the transaction referred to herein; (ii) changes in market conditions or deterioration in underlying investments; (iii) general economic, market, financing, regulatory and industry developments and conditions; and (iv) other risk factors set forth in Westaim's Annual Report or Annual Information Form. Westaim disclaims any intention or obligation to revise forward-looking statements whether as a result of new information, future developments or otherwise except as required by law. All forward-looking statements are expressly qualified in their entirety by this cautionary statement.

*Permission to use quotations from the RiskMetrics report was neither sought nor obtained.

SOURCE Westaim Corporation

Back to top
'/>"/>
SOURCE Westaim Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. Westaim commences mailing of management information circular and announces new director
2. Westaim announces 2009 third quarter results
3. Westaim announces 2009 second quarter results
4. Westaim announces 2009 first quarter results
5. Westaim enters into Management Services Agreement
6. Westaim announces 2008 year-end results
7. The Westaim Corporation requisitions meeting of shareholders of NUCRYST Pharmaceuticals to return capital to NUCRYST shareholders
8. Westaim announces 2008 third quarter results
9. Webcast Advisory - The Westaim Corporation Webcast of Conference Call to Discuss 2008 Third Quarter Results
10. Westaim terminates reorganization agreement and cancels shareholders meeting
11. Westaim to deregister its common stock in the United States
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... CA (PRWEB) , ... February 21, 2017 , ... Doctors ... , CA, directed by Dr. Kendell Mendonca , to its growing network of ... compensation injuries including injuries stemming from car accidents such as whiplash, back pain, neck ...
(Date:2/21/2017)... ... , ... Ray Insurance Agencies, a Dallas area firm providing asset protection services ... a six month charity event aimed at raising local support and donations that will ... the deadliest diseases in America; more than 7.5 million people die from cancer related ...
(Date:2/21/2017)... ... February 21, 2017 , ... ... the further expansion of its eHealth App xChange™, providing clinical researchers more ... Bioclinica’s extensive and growing eHealth platform. Applications that enable patient-centered clinical trials ...
(Date:2/21/2017)... ... February 21, 2017 , ... HIMSS is the ... care demonstration spanned multiple health information systems including OpenEMR, EMRDirect, and Epic. ... have no Health Information Exchange outside of faxing. Medal’s innovative technology “meets providers ...
(Date:2/21/2017)... (PRWEB) , ... February 21, 2017 , ... ... coffee house-caliber protein espresso drinks, announced its products are now available for purchase ... Coffee Protein Drink Mix has become popular among health-conscious consumers who love coffee ...
Breaking Medicine News(10 mins):
(Date:2/21/2017)... 2017 Sangamo Therapeutics, Inc. (Nasdaq: SGMO), the ... company will release its fourth quarter and full year ... February 28, 2017. The press release will be followed ... will be open to the public via telephone and ... its financial results and provide a business update. ...
(Date:2/21/2017)... , Feb. 21, 2017 ... announced a new imaging solution that connects Lexmark multifunction ... one of the world,s leading scanning and indexing software ... Connector enables hospitals to use a Lexmark MFP at ... the Solarity workflow, helping facilities reach HIMSS Stage ...
(Date:2/21/2017)... 2017 EMS Find, Inc. (OTCQB: EMSF), ... platforms with focus on e-commerce, health care and ... a worldwide, on-revocable and renewable Software Licensing and ... company serving healthcare organizations and facilities throughout ... EpicMD,s platform eliminates the need for health ...
Breaking Medicine Technology: